Strong game performance for the price. Lots of ports. The keyboard and touchpad punch above their weight. Decent build quality. Unheard-of value. The included 135-watt charger isn't sufficient. The ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Matt Elliott is a senior editor ...

If you currently own an Alesis Nitro Max and are thinking of upgrading, it’s more likely that you’ll skip the increment and head straight to the Strata series. However, if you’re upgrading from an ...

Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that the Company ...

LONDON & SEATTLE, June 03, 2025--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd. ("Tenpoint"), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical trials among patients with presbyopia. Tenpoint Therapeutics announced the ...

Please provide your email address to receive an email when new articles are posted on . The submission is supported by positive data from the phase 3 BRIO-I and BRIO-II studies. If approved, Brimochol ...

Tenpoint Therapeutics has tasked Carol Kearney with cracking a market that confounded AbbVie. As the biotech’s newly appointed chief commercial officer, Kearney will oversee preparations to launch a ...

LONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the ...

Leading Pharmaceutical Executive Strengthens Leadership Team as Tenpoint Prepares for the Potential Commercial Launch of BRIMOCHOL™ PF LONDON & SEATTLE, March 11, 2025--(BUSINESS WIRE)--Tenpoint ...

In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients with presbyopia for up to eight hours. The top-line results come from ...

Please provide your email address to receive an email when new articles are posted on . The merged company plans to file a new drug application for its presbyopia-correcting eye drop in 2025. Henric ...